by Zyg Dembek | Aug 10, 2021 | Article, Covid-19
Col Zyg Dembek delivers an update on progress in the vaccination effort and asks if we can look to a Covid-free future By mid-June 2021, almost 42% of the US population had been fully vaccinated against Covid-19, with about 52% having received one vaccine dose. In the...
by Deborah Carr | Apr 1, 2021 | Article, Covid-19
Deborah Carr assesses the onslaught and effects of evolving SARS-CoV-2 variants Eighteen months into the pandemic, scientists, policy makers and the public at large are concerned about variants of the SARS-CoV-2 virus that have appeared and spread globally. Could...
by Deborah Carr | Jan 25, 2021 | Article, Covid-19
Deborah Carr examines the long-term effects of coronavirus infection. ‘Long Haulers’ or ‘Long Covid’ are terms coined to describe those still struggling to recover from Covid-19 symptoms months after being infected. In July 2020 Chinese researchers launched one of the...
by SJ | Sep 3, 2020 | Article, Covid-19
Proud to save lives Antoine Bernasconi, CCO of SERB Specialty Pharmaceuticals, describes the achievements of this leading pharmaceutical company CBNW: Please could you outline the history of SERB? AB: SERB Specialty Pharmaceuticals is a leading pan-European specialty...
by SJ | Sep 3, 2020 | Article, Covid-19
Neeraja Venkateswaran and Roma Venkateswaran explain the importance of testing as a tool against COVID-19 An outbreak of 27 cases of atypical viral pneumonia was first reported on 31 December 2019, in Wuhan, China. On that day, the Avian Flu Diary blog noted that...
by blloyd | Jun 22, 2020 | Article, Covid-19
Caused by the novel coronavirus SARS-CoV-2, there is so much that we do not know yet about the virus causing this pandemic – despite its rampant path worldwide since it was first detected last year in the city of Wuhan, in Hubei Province in China. As of April, at...
Recent Comments